Compounds > difloxacin
Page last updated: 2024-08-24

difloxacin and Infections, Staphylococcal

difloxacin has been researched along with Infections, Staphylococcal in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cárceles, CM; Fernández-varón, E; García-Martínez, JD; Marín, P; Montes, A; Sotillo, J; Vancraeynest, D1
Boscia, JA; Kaye, D; Kobasa, WD1
Bower, RR; Chu, DT; Fernandes, PB; Jarvis, KP; Ramer, NR; Shipkowitz, N1
Adams, KR; Mader, JT; Morrison, LT1

Other Studies

4 other study(ies) available for difloxacin and Infections, Staphylococcal

ArticleYear
Disposition kinetics and pharmacokinetics--pharmacodynamic integration of difloxacin against Staphylococcus aureus isolates from rabbits.
    Research in veterinary science, 2008, Volume: 84, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Cross-Over Studies; Fluoroquinolones; Injections, Intravenous; Injections, Subcutaneous; Rabbits; Staphylococcal Infections; Staphylococcus aureus

2008
Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:2

    Topics: Administration, Oral; Animals; Anti-Infective Agents; Cefazolin; Ciprofloxacin; Endocarditis, Bacterial; Enoxacin; Female; Fluoroquinolones; Half-Life; Injections, Intramuscular; Naphthyridines; Rabbits; Staphylococcal Infections

1988
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
    Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2

    Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Fluoroquinolones; Half-Life; Immunosuppression Therapy; Klebsiella Infections; Mice; Norfloxacin; Piperazines; Proteus Infections; Pseudomonas Infections; Pyelonephritis; Quinolines; Salmonella Infections, Animal; Staphylococcal Infections; Streptococcal Infections

1986
Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Ciprofloxacin; Fluoroquinolones; Nafcillin; Osteomyelitis; Rabbits; Random Allocation; Staphylococcal Infections; Staphylococcus aureus; Tissue Distribution

1987